HIV-1 decreases Nrf2/ARE activity and phagocytic function in alveolar macrophages

Journal of Leukocyte Biology

Volumn 102, Issue 2, 2017, Pages 517-525

  Staitieh, Bashar S ^a   Ding, Lingmei ^a   Neveu, Wendy A ^a   Spearman, Paul ^a   Guidot, David M ^a,b   Fan, Xian ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Alveolar space; Antioxidant response element; HIV related viral proteins

Indexed keywords

GLUTAMATE CYSTEINE LIGASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE) 1; RNA; SULFORAPHANE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; NFE2L2 PROTEIN, HUMAN;

ANIMAL CELL; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVE SITE; EX VIVO STUDY; GENE SILENCING; HIV-1 TRANSGENIC RAT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE CELL LINE; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS; WILD TYPE; ANIMAL; FISCHER 344 RAT; GENE EXPRESSION REGULATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; PHAGOCYTOSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC RAT; VIROLOGY; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANT RESPONSE ELEMENTS; BLOTTING, WESTERN; GENE EXPRESSION REGULATION; HIV INFECTIONS; HIV-1; HUMANS; MACROPHAGES, ALVEOLAR; NF-E2-RELATED FACTOR 2; PHAGOCYTOSIS; RATS; RATS, INBRED F344; RATS, TRANSGENIC; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 85026740958     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.4A0616-282RR     Document Type: Article

References (42)

1. Hull, M. W., Phillips, P., Montaner, J. S. (2008) Changing global epidemiology of pulmonary manifestations of HIV/AIDS. Chest 134, 1287–1298.
2. Staitieh, B., Guidot, D. M. (2014) Noninfectious pulmonary complications of human immunodeficiency virus infection. Am. J. Med. Sci. 348, 502–511.
3. Noursadeghi, M., Katz, D. R., Miller, R. F. (2006) HIV-1 infection of mononuclear phagocytic cells: the case for bacterial innate immune deficiency in AIDS. Lancet Infect. Dis. 6, 794–804.
4. Kedzierska, K., Azzam, R., Ellery, P., Mak, J., Jaworowski, A., Crowe, S. M. (2003) Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: underlying mechanisms and modulation by adjunctive cytokine therapy. J. Clin. Virol. 26, 247–263.
5. Cribbs, S. K., Lennox, J., Caliendo, A. M., Brown, L. A., Guidot, D. M. (2015) Healthy HIV-1-infected individuals on highly active antiretroviral therapy harbor HIV-1 in their alveolar macrophages. AIDS Res. Hum. Retroviruses 31, 64–70.
6. Morris, D., Guerra, C., Donohue, C., Oh, H., Khurasany, M., Venketaraman, V. (2012) Unveiling the mechanisms for decreased glutathione in individuals with HIV infection. Clin. Dev. Immunol. 2012, 734125.
7. Jacob, B. A., Porter, K. M., Elms, S. C., Cheng, P. Y., Jones, D. P., Sutliff, R. L. (2006) HIV-1-induced pulmonary oxidative and nitrosative stress: exacerbated response to endotoxin administration in HIV-1 transgenic mouse model. Am. J. Physiol. Lung Cell. Mol. Physiol. 291, L811–L819.
8. Biswal, S., Thimmulappa, R. K., Harvey, C. J. (2012) Experimental therapeutics of Nrf2 as a target for prevention of bacterial exacerbations in COPD. Proc. Am. Thorac. Soc. 9, 47–51.
9. Harvey, C. J., Thimmulappa, R. K., Sethi, S., Kong, X., Yarmus, L., Brown, R. H., Feller-Kopman, D., Wise, R., Biswal, S. (2011) Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model. Sci. Transl. Med. 3, 78ra32.
10. Jensen, J. S., Fan, X., Guidot, D. M. (2013) Alcohol causes alveolar epithelial oxidative stress by inhibiting the nuclear factor (erythroid-derived 2)-like 2-antioxidant response element signaling pathway. Am. J. Respir. Cell Mol. Biol. 48, 511–517.
11. Fan, X., Staitieh, B. S., Jensen, J. S., Mould, K. J., Greenberg, J. A., Joshi, P. C., Koval, M., Guidot, D. M. (2013) Activating the Nrf2-mediated antioxidant response element restores barrier function in the alveolar epithelium of HIV-1 transgenic rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 305, L267–L277.
12. Lu, S. C. (2013) Glutathione synthesis. Biochim. Biophys. Acta 1830, 3143–3153.
13. Staitieh, B. S., Fan, X., Neveu, W., Guidot, D. M. (2015) Nrf2 regulates PU.1 expression and activity in the alveolar macrophage. Am. J. Physiol. Lung Cell. Mol. Physiol. 308, L1086–L1093.
14. Joshi, P. C., Raynor, R., Fan, X., Guidot, D. M. (2008) HIV-1-transgene expression in rats decreases alveolar macrophage zinc levels and phagocytosis. Am. J. Respir. Cell Mol. Biol. 39, 218–226.
15. Herbein, G., Varin, A. (2010) The macrophage in HIV-1 infection: from activation to deactivation? Retrovirology 7, 33.
16. Lassiter, C., Fan, X., Joshi, P. C., Jacob, B. A., Sutliff, R. L., Jones, D. P., Koval, M., Guidot, D. M. (2009) HIV-1 transgene expression in rats causes oxidant stress and alveolar epithelial barrier dysfunction. AIDS Res. Ther. 6, 1.
17. Yuan, Z., Fan, X., Staitieh, B., Bedi, C., Spearman, P., Guidot, D. M., Sadikot, R. T. (2017) HIV-related proteins prolong macrophage survival through induction of triggering receptor expressed on myeloid cells-1. Sci. Rep. 7, 42028.
18. Chu, H., Wang, J. J., Qi, M., Yoon, J. J., Chen, X., Wen, X., Hammonds, J., Ding, L., Spearman, P. (2012) Tetherin/BST-2 is essential for the formation of the intracellular virus-containing compartment in HIV-infected macrophages. Cell Host Microbe 12, 360–372.
19. Joshi, P. C., Raynor, R., Fan, X., Guidot, D. M. (2008) HIV-1 transgenic expression in rats decreases alveolar macrophage zinc levels and phagocytosis. Am. J. Respir. Cell. Mol. Biol. 39, 218–226.
20. Reid, W., Sadowska, M., Denaro, F., Rao, S., Foulke, J., Jr., Hayes, N., Jones, O., Doodnauth, D., Davis, H., Sill, A., O’Driscoll, P., Huso, D., Fouts, T., Lewis, G., Hill, M., Kamin-Lewis, R., Wei, C., Ray, P., Gallo, R. C., Reitz, M., Bryant, J. (2001) An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc. Natl. Acad. Sci. USA 98, 9271–9276.
21. Staitieh, B. S., Egea. E. E., Fan, X., Azih, N., Guidot, D. M. (2015) Activation of alveolar macrophages with interferon-γ promotes antioxidant defenses via the Nrf2-ARE pathway. J. Clin. Cell. Immunol. 6, 365.
22. Baruchel, S., Wainberg, M. A. (1992) The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus. J. Leukoc. Biol. 52, 111–114.
23. Cribbs, S. K., Guidot, D. M., Martin, G. S., Lennox, J., Brown, L. A. (2014) Anti-retroviral therapy is associated with decreased alveolar glutathione levels even in healthy HIV-infected individuals. PLoS One 9, e88630.
24. Jambo, K. C., Banda, D. H., Kankwatira, A. M., Sukumar, N., Allain, T. J., Heyderman, R. S., Russell, D. G., Mwandumba, H. C. (2014) Small alveolar macrophages are infected preferentially by HIV and exhibit impaired phagocytic function. Mucosal Immunol. 7, 1116–1126.
25. Harrold, S. M., Wang, G., McMahon, D. K., Riddler, S. A., Mellors, J. W., Becker, J. T., Caldararo, R., Reinhart, T. A., Achim, C. L., Wiley, C. A. (2002) Recovery of replication-competent HIV type 1-infected circulating monocytes from individuals receiving antiretroviral therapy. AIDS Res. Hum. Retroviruses 18, 427–434.
26. Segal, L. N., Methé, B. A., Nolan, A., Hoshino, Y., Rom, W. N., Dawson, R., Bateman, E., Weiden, M. D. (2011) HIV-1 and bacterial pneumonia in the era of antiretroviral therapy. Proc. Am. Thorac. Soc. 8, 282–287.
27. Debaisieux, S., Lachambre, S., Gross, A., Mettling, C., Besteiro, S., Yezid, H., Henaff, D., Chopard, C., Mesnard, J. M., Beaumelle, B. (2015) HIV-1 Tat inhibits phagocytosis by preventing the recruitment of Cdc42 to the phagocytic cup. Nat. Commun. 6, 6211.
28. Kedzierska, K., Mak, J., Mijch, A., Cooke, I., Rainbird, M., Roberts, S., Paukovics, G., Jolley, D., Lopez, A., Crowe, S. M. (2000) Granulocyte-macrophage colony-stimulating factor augments phagocytosis of Mycobacterium avium complex by human immunodeficiency virus type 1-infected monocytes/macrophages in vitro and in vivo. J. Infect. Dis. 181, 390–394.
29. Riddell, L. A., Pinching, A. J., Hill, S., Ng, T. T., Arbe, E., Lapham, G. P., Ash, S., Hillman, R., Tchamouroff, S., Denning, D. W., Parkin, J. M. (2001) A phase III study of recombinant human interferon gamma to prevent opportunistic infections in advanced HIV disease. AIDS Res. Hum. Retroviruses 17, 789–797.
30. Elbim, C., Pillet, S., Prevost, M. H., Preira, A., Girard, P. M., Rogine, N., Hakim, J., Israel, N., Gougerot-Pocidalo, M. A. (2001) The role of phagocytes in HIV-related oxidative stress. J. Clin. Virol. 20, 99–109.
31. Kobayashi, E., Suzuki, T., Yamamoto, M. (2013) Roles Nrf2 plays in myeloid cells and related disorders. Oxid. Med. Cell. Longev. 2013, 529219.
32. Brüne, B., Dehne, N., Grossmann, N., Jung, M., Namgaladze, D., Schmid, T., von Knethen, A., Weigert, A. (2013) Redox control of inflammation in macrophages. Antioxid. Redox Signal. 19, 595–637.
33. Sussan, T. E., Rangasamy, T., Blake, D. J., Malhotra, D., El-Haddad, H., Bedja, D., Yates, M. S., Kombairaju, P., Yamamoto, M., Liby, K. T., Sporn, M. B., Gabrielson, K. L., Champion, H. C., Tuder, R. M., Kensler, T. W., Biswal, S. (2009) Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice. Proc. Natl. Acad. Sci. USA 106, 250–255.
34. Gill, A. J., Kolson, D. L. (2013) Dimethyl fumarate modulation of immune and antioxidant responses: application to HIV therapy. Crit. Rev. Immunol. 33, 307–359.
35. Zhang, D. D., Hannink, M. (2003) Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell. Biol. 23, 8137–8151.
36. Suganuma, H., Fahey, J. W., Bryan, K. E., Healy, Z. R., Talalay, P. (2011) Stimulation of phagocytosis by sulforaphane. Biochem. Biophys. Res. Commun. 405, 146–151.
37. Kanmogne, G. D., Primeaux, C., Grammas, P. (2005) HIV-1 gp120 proteins alter tight junction protein expression and brain endothelial cell permeability: implications for the pathogenesis of HIV-associated dementia. J. Neuropathol. Exp. Neurol. 64, 498–505.
38. András, I. E., Pu, H., Deli, M. A., Nath, A., Hennig, B., Toborek, M. (2003) HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells. J. Neurosci. Res. 74, 255–265.
39. Otis, J. S., Ashikhmin, Y. I., Brown, L. A., Guidot, D. M. (2008) Effect of HIV-1-related protein expression on cardiac and skeletal muscles from transgenic rats. AIDS Res. Ther. 5, 8.
40. Kline, E. R., Kleinhenz, D. J., Liang, B., Dikalov, S., Guidot, D. M., Hart, C. M., Jones, D. P., Sutliff, R. L. (2008) Vascular oxidative stress and nitric oxide depletion in HIV-1 transgenic rats are reversed by glutathione restoration. Am. J. Physiol. Heart Circ. Physiol. 294, H2792–H2804.
41. Rich, E. A., Chen, I. S., Zack, J. A., Leonard, M. L., O’Brien, W. A. (1992) Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J. Clin. Invest. 89, 176–183.
42. Coleman, C. M., Wu, L. (2009) HIV interactions with monocytes and dendritic cells: viral latency and reservoirs. Retrovirology 6, 51.